Home » Events » TPR’s Think Science: “A new era for advancing brain health”

TPR’s Think Science: “A new era for advancing brain health”

Event Details:
The University of Texas Health Science Center at San Antonio’s new Center for Brain Health, opening in December 2025, will bring together innovative research, leading-edge clinical care and compassionate caregiver support together under one roof to revolutionize how we understand and treat diseases of the brain. The center is designed to provide a comprehensive and hopeful experience for individuals facing neurological diseases, while advancing the science behind diagnosis and treatment.

Join us for a special evening as we work together towards a brighter future for advancing brain health in South Texas.

Doors open: 6:30 p.m.

Presentation: 7 – 8 p.m.

Featured Speakers

Nathan Cone from Texas Public Radio (TPR) will moderate the hourlong event. Click the links below to learn more about these world-renowned experts.

Sudha Seshadri, MD, tenured professor in the Department of Neurology and founding director, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases whose research focuses on uncovering the biology of Alzheimer’s and related dementias, stroke and vascular brain injury. She continues to see patients and lead clinical trials of promising therapies.

Elena Volpi, MD, professor in the Department of Medicine, Division of Geriatrics, Gerontology and Palliative Medicine and director of the Sam and Ann Barshop Institute for Longevity and Aging Studies. Her research centers on understanding the mechanisms behind involuntary muscle loss in aging and developing innovative treatments—nutritional, exercise and pharmacological—to enhance muscle growth and recovery in older adults.

Matthew Wicklund, MD, professor in the Department of Neurology and director, Muscular Dystrophy Association (MDA) Multidisciplinary Care Center whose research focuses on recent advancements in the treatment of Parkinson's disease, stroke management and outcomes, and the development of genetics-based therapies for neurological disorders.